Protective Effect of rPb40 as an Adjuvant for Chemotherapy in Experimental Paracoccidioidomycosis

Mycopathologia

Volumn 174, Issue 2, 2012, Pages 93-105

  Fernandes, V C ^a   Martins, E M N ^a   Boeloni, J N ^a   Serakides, R ^a   Goes, A M ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Paracoccidioides brasiliensis; Paracoccidioidomycosis; rPb40; Therapeutic vaccine

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; FUNGUS ANTIBODY; FUNGUS ANTIGEN; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 10; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BLOOD; DRUG THERAPY; GENETICS; IMMUNOTHERAPY; ISOLATION AND PURIFICATION; LIVER; METHODOLOGY; MICROBIOLOGY; MOUSE; SOUTH AMERICAN BLASTOMYCOSIS; SPLEEN; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, FUNGAL; ANTIFUNGAL AGENTS; ANTIGENS, FUNGAL; DRUG THERAPY; FLUCONAZOLE; IMMUNOGLOBULIN G; IMMUNOTHERAPY; INTERLEUKIN-10; LIVER; MICE; MICE, INBRED BALB C; PARACOCCIDIOIDOMYCOSIS; RECOMBINANT PROTEINS; SPLEEN; TREATMENT OUTCOME;

ANIMALIA; ESCHERICHIA COLI; MUS; PARACOCCIDIOIDES BRASILIENSIS;

EID: 84864284393     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-012-9530-2     Document Type: Article

References (34)

1. Visbal G, San-Blas G, Murgich J, Franco H. Paracoccidioides brasiliensis, paracoccidioidomycosis, and antifungal antibiotics. Curr Drug Targets Infect Disord. 2005; 5: 211-26.
2. Odds FC, Brown AJ, Gow NA. Antifungal agents: mechanisms of action. Trends Microbiol. 2003; 11: 272-9.
3. San-Blas G, Nino-Vega G. Paracoccidioides brasiliensis: chemical and molecular tools for research on cell walls, antifungals, diagnosis, taxonomy. Mycopathologia. 2008; 165: 183-95.
4. Marques AF, da Silva MB, Juliano MA, Travassos LR, Taborda CP. Peptide immunization as an adjuvant to chemotherapy in mice challenged intratracheally with virulent yeast cells of Paracoccidioides brasiliensis. Antimicrob Agents Chemother. 2006; 50: 2814-9.
5. Marques AF, da Silva MB, Juliano MA, Munhoz JE, Travassos LR, Taborda CP. Additive effect of P10 immunization and chemotherapy in anergic mice challenged intratracheally with virulent yeasts of Paracoccidioides brasiliensis. Microbes Infect. 2008; 10: 1251-8.
6. Diniz SN, Reis BS, Goes TS, Zouain CS, Leite MF, Goes AM. Protective immunity induced in mice by F0 and FII antigens purified from Paracoccidioides brasiliensis. Vaccine. 2004; 22: 485-92.
7. Goes TS, Goes VS, Kalapothakis E, Leite MF, Goes AM. Identification of immunogenic proteins from Paracoccidioides brasiliensis antigenic fractions F0, FII and FIII. Immunol Lett. 2005; 101: 24-31.
8. Araujo Sde A, Prado Lde G, Veloso JM, Pedroso ER. Case of recurrent Paracoccidioidomycosis: 25 years after initial treatment. Braz J Infect Dis. 2009; 13: 394.
9. Dias MF, Mesquita J, Rodrigues N, Filgueira AL, De Souza W. Viability of yeast form cells of Paracoccidioides brasiliensis after sonication. Med Mycol. 2004; 42: 43-9.
10. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA. 1977; 74: 5463-7.
11. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227: 680-5.
12. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA. 1979; 76: 4350-4.
13. Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, Mathieu C. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods. 2001; 25: 386-401.
14. Reis BS, Fernandes VC, Martins EM, Serakides R, Goes AM. Protective immunity induced by rPb27 of Paracoccidioides brasiliensis. Vaccine. 2008; 26: 5461-9.
15. Ribeiro AM, Bocca AL, Amaral AC, et al. HSP65 DNA as therapeutic strategy to treat experimental paracoccidioidomycosis. Vaccine. 2010; 28: 1528-34.
16. Rennick D, Davidson N, Berg D. Interleukin-10 gene knock-out mice: a model of chronic inflammation. Clin Immunol Immunopathol. 1995; 76: S174-8.
17. Grunig G, Corry DB, Leach MW, Seymour BW, Kurup VP, Rennick DM. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J Exp Med. 1997; 185: 1089-99.
18. Del Sero G, Mencacci A, Cenci E, et al. Antifungal type 1 responses are upregulated in IL-10-deficient mice. Microbes Infect. 1999; 1: 1169-80.
19. Peracoli MT, Kurokawa CS, Calvi SA, et al. Production of pro- and anti-inflammatory cytokines by monocytes from patients with paracoccidioidomycosis. Microbes Infect. 2003; 5: 413-8.
20. Cano LE, Singer-Vermes LM, Vaz CA, Russo M, Calich VL. Pulmonary paracoccidioidomycosis in resistant and susceptible mice: relationship among progression of infection, bronchoalveolar cell activation, cellular immune response, and specific isotype patterns. Infect Immun. 1995; 63: 1777-83.
21. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature. 1996; 383: 787-93.
22. Kopf M, Le Gros G, Bachmann M, Lamers MC, Bluethmann H, Kohler G. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature. 1993; 362: 245-8.
23. Shimoda K, van Deursen J, Sangster MY, et al. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature. 1996; 380: 630-3.
24. Hart PH, Vitti GF, Burgess DR, Whitty GA, Piccoli DS, Hamilton JA. Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2. Proc Natl Acad Sci USA. 1989; 86: 3803-7.
25. Tanaka T, Hu-Li J, Seder RA. Fazekas de St Groth B, Paul WE. Interleukin 4 suppresses interleukin 2 and interferon gamma production by naive T cells stimulated by accessory cell-dependent receptor engagement. Proc Natl Acad Sci USA. 1993; 90: 5914-8.
26. Arruda C, Valente-Ferreira RC, Pina A, et al. Dual role of interleukin-4 (IL-4) in pulmonary paracoccidioidomycosis: endogenous IL-4 can induce protection or exacerbation of disease depending on the host genetic pattern. Infect Immun. 2004; 72: 3932-40.
27. Souto JT, Figueiredo F, Furlanetto A, Pfeffer K, Rossi MA, Silva JS. Interferon-gamma and tumor necrosis factor-alpha determine resistance to Paracoccidioides brasiliensis infection in mice. Am J Pathol. 2000; 156: 1811-20.
28. McIntyre TM, Klinman DR, Rothman P, et al. Transforming growth factor beta 1 selectivity stimulates immunoglobulin G2b secretion by lipopolysaccharide-activated murine B cells. J Exp Med. 1993; 177: 1031-7.
29. Snapper CM, Marcu KB, Zelazowski P. The immunoglobulin class switch: beyond "accessibility". Immunity. 1997; 6: 217-23.
30. Calich VL, Vaz CA, Burger E. Immunity to Paracoccidioides brasiliensis infection. Res Immunol 1998; 149: 407-17; discussion 99-500.
31. Kashino SS, Fazioli RA, Cafalli-Favati C, et al. Resistance to Paracoccidioides brasiliensis infection is linked to a preferential Th1 immune response, whereas susceptibility is associated with absence of IFN-gamma production. J Interferon Cytokine Res. 2000; 20: 89-97.
32. Cano LE, Kashino SS, Arruda C, et al. Protective role of gamma interferon in experimental pulmonary paracoccidioidomycosis. Infect Immun. 1998; 66: 800-6.
33. Polonelli L, Casadevall A, Han Y, et al. The efficacy of acquired humoral and cellular immunity in the prevention and therapy of experimental fungal infections. Med Mycol. 2000; 38(Suppl 1): 281-92.
34. de Mattos Grosso D, de Almeida SR, Mariano M, Lopes JD. Characterization of gp70 and anti-gp70 monoclonal antibodies in Paracoccidioides brasiliensis pathogenesis. Infect Immun. 2003; 71: 6534-42.